Sorry, you need to enable JavaScript to visit this website.

Our Policies on Ethics

As we work to develop new medicines, our strict standards of moral and ethical conduct are guided by the help and oversight of institutional review boards, regulatory authorities, and industry association guidelines governing ethical clinical trial conduct and research integrity. Additionally, we have created our own agency to oversee our research ethics and integrity. 

All Pfizer-sponsored interventional studies are conducted in accordance with applicable laws and regulations, as well as principles derived from relevant international standards including: 

  • The Council for International Organizations of Medical Sciences (CIOMS) International Ethical Guidelines 

  • The International Council for Harmonization of Technical Requirements for Pharmaceuticals for Human Use (ICH) E6 guideline for Good Clinical Practice 

  • PhRMA’s Principles on Conduct of Clinical Trials and Communication of Clinical Trial Results 

  • The Declaration of Helsinki 

  • The United States Belmont report 

We strive to maintain the highest ethical, scientific, and clinical standards in all our clinical research around the world. We regularly review our policies to align them with Pfizer's vision, values, and goals, and with our stakeholders' evolving priorities.

Related Articles

Science & Innovation

Spotting the Signs of ATTR-CM: Latest Data Reveals Opportunities for More Timely Detection

For many people living with transthyretin amyloid cardiomyopathy (ATTR‑CM) – a rare and underdiagnosed cause of heart failure – receiving an accurate diagnosis can be a long and uncertain journey.

Elderly man speaking with healthcare professional thumbnail

Science & Innovation

As Colorectal Cancer Rises in Younger Populations, Research and Education is More Important than Ever

At one time, colorectal cancer was a disease associated with older adults. Now, it’s considered the most deadly cancer in people younger than 50.

Up close image of a cell, thumbnail

Real People

One Pediatric Gastroenterologist’s Mission to Expand Pediatric Treatment Options

Dr. Nicole Kulisek shares her path from pediatric gastroenterologist to US Medical Affairs leader at Pfizer.

Nicole, IBD discussion panel thumbnail

Clinical Trials

We proudly partner with thousands of study sites and tens of thousands of trial participants around the world. It’s these clinical trials that lead to life-changing medicines.

Go to Pfizer Clinical Trials Site Details